164 related articles for article (PubMed ID: 11959614)
1. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
3. Gemifloxacin is effective in experimental pneumococcal meningitis.
Smirnov A; Wellmer A; Gerber J; Maier K; Henne S; Nau R
Antimicrob Agents Chemother; 2000 Mar; 44(3):767-70. PubMed ID: 10681354
[TBL] [Abstract][Full Text] [Related]
4. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
[TBL] [Abstract][Full Text] [Related]
6. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
[TBL] [Abstract][Full Text] [Related]
7. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
8. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
[TBL] [Abstract][Full Text] [Related]
10. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Kim YS; Liu Q; Chow LL; Täuber MG
Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of gemifloxacin and other quinolones against Streptococcus pneumoniae.
Morrissey I; George JT
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():107-10. PubMed ID: 10824041
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics to combat resistance.
Woodnutt G
J Antimicrob Chemother; 2000 Jul; 46 Suppl T1():25-31. PubMed ID: 10997596
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
14. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
Klugman KP; Gootz TD
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
[TBL] [Abstract][Full Text] [Related]
17. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
[TBL] [Abstract][Full Text] [Related]
18. Activities of ertapenem, a new long-acting carbapenem, against penicillin-sensitive or -resistant pneumococci in experimental meningitis.
Cottagnoud P; Pfister M; Cottagnoud M; Acosta F; Täuber MG
Antimicrob Agents Chemother; 2003 Jun; 47(6):1943-7. PubMed ID: 12760871
[TBL] [Abstract][Full Text] [Related]
19. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
[TBL] [Abstract][Full Text] [Related]
20. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
